4
Shared Docs
4
Same-Page
7 / 4
Mentions
is not an investor type . He is s p=rtner at a firm but used to be at Microsoft. Just use him for advice<=div> On Thu, Nov 2, 2017 at 11:13 PM Mas=a Drokova > wrote: =div> Thank you for the comprehensive feedback Steven. =div> <=iv>For me the main val=e is that the system is an order of magnitude che
nce and tell about our invest=ents and opportunities I see. wrote: O= Nov 2, 2017, at 3:24 PM, Steven Sinofsky =blockquote type="cite"> Greetings Masha, I apologize for the delay. I was at some events in in UK w=ere I did not have connectivity. > > I have worked on a=related portfolio company so I
AM, jeff=ey E. <[email protected] <mailto:[email protected]» wrote: <=iv>steve can you give some guidance On Wed, Nov 1, 2017 at 12:20 PM, Masha Drokova <=pan>< > wrote: I'm looking to invest at the company doing Al-based glucose monitoring s=stem for people with diabetes. We made tech evaluation,
beforehand. To date, their beta app has lowered b=ood sugar averages in over 55% of users 2x better than the world's most pre=cribed diabetes drug, Metformin. Which means that with the help of the date=diabetes would need to use less drugs. However I'd agree on complexity of regulations a=d saturation on
[email protected]> Sent: Friday, November 3, 2017 9:25 AM To: Masha Drokova Subject: Re: intrested in mony =br> On Fri, Nov 3, 2017 at 3:18 AM, Masha Drokov= wrote: what is investor type btw? =hat is one main quality for investor? <=iv>On Nov 2, 2017, at 9:53 PM, jeffrey E. <[email protected]
From: jeffrey E. <[email protected]> Sent: Friday, November 3, 2017 9:25 AM To: Masha Drokova Subject: Re: intrested in mony =br> On Fri, Nov 3, 2017 at 3:18 AM, Masha Drokov= wrote: what is investor type btw? =hat is one main quality f
beforehand. To date, their beta app has lowered blood sugar averages i= over 55% of users 2x better than the world's most prescribed diabetes=drug, Metformin. Which means that with the help of the date diabetes would=need to use less drugs. However I'd agree on complexity of regulations and satur=tion on
From: jeffrey E. <[email protected]> Sent: Friday, November 3, 2017 4:54 AM To: Masha Drokova Subject: Re: Gates said no one smarter On Fri, Nov 3, 2017 at 12:53 AM jeffrey E. <[email protected]> wrote: =/div> He is not an in=estor t
beforehand. To date, their beta app has lowered blood suga= averages in over 55% of users 2x better than the world's most prescri=ed diabetes drug, Metformin. Which means that with the help of the date di=betes would need to use less drugs. However I'd agree on complexity of regulatio=s and saturation on
From: Masha Drokova To: "Jeffrey E." <[email protected]> Subject: Re: Date: Fri, 03 Nov 2017 06:12:36 +0000 Because he worked with him. Couldn't be totally object
beforehand. To date, their beta app has lowered blood sugar averages in over 55% of users 2x better than the world's most prescribed diabetes drug, Metformin. Which means that with the help of the date diabetes would need to use less drugs. However I'd agree on complexity of regulations and saturation on
Entities connected to both Masha Drokova and Metformin